Category: Drug manufacturing

Following unprecedented demand, Eli Lilly resolved the widespread Zepbound shortage by investing billions in manufacturing expansions and strategic supply chain initiatives. This ultimately led the FDA to declare the tirzepatide supply issues resolved by December 2024.

First approved by the FDA in 2017, Roxybond was a significant advancement as an abuse-deterrent, immediate-release opioid. Many people wonder, **Who makes Roxybond?**, and the journey from its initial developer to its current manufacturer is a key part of understanding this medication and its place in pain management.

Over 90% of a drug's therapeutic effect comes from its active component. This critical ingredient, known as the Active Pharmaceutical Ingredient (API), is what makes a medication effective at treating a specific disease or symptom, and understanding **what is API in pharma?** is fundamental to grasping drug manufacturing.

The acronym AFS can refer to multiple distinct technologies and services within the pharmaceutical industry, and the interpretation depends heavily on the context. While one major application, Atomic Fluorescence Spectroscopy (AFS), is a key analytical method used for detecting trace metal contaminants in drugs, the term also encompasses Advanced Formulation Services and Automated Formulation Systems that drive innovation in drug delivery and manufacturing.